44 Results for "

Atg5

" in MedChemExpress (MCE) Product Catalog:
Products (44)

44 Results for "Atg5" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-W018791
CAS No.: 73536-69-3
Synonyms: DDB
Bifendate (DDB), extracted from Schisandrae chinensis, is an orally active anti-HBV agent against chronic hepatitis B. Bifendate inhibits ATG5-dependent autophagy and attenuates oleic acid-induced lipid accumulation with anti-oxidant properties in vitro. Bifendate can decrease alanine transaminase (ALT) level in mice. Bifendate attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice. Bifendate potently increases the activity of cytochrome proteins (CYPs) and reverse P-gp-mediated multi-drug resistance (MDR) [5] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N3415
CAS No.: 3301-49-3
Kumatakenin is an orally active apoptosis inducer and autophagy inhibitor, with a Kd value of 2.94 μM for mouse ATG5. Kumatakenin increases the activities of caspase-3, caspase-8 and caspase-9, thereby inducing caspase-dependent apoptosis in ovarian cancer cells. Kumatakenin reduces the expression of chemokines and pro-oncogenic factors in ovarian cancer cells, and inhibits M2 macrophage polarization. Kumatakenin inactivates TRIM65 function, reduces the expression and stability of FASN, and thus inhibits the proliferation, migration, invasion and tumor progression of esophageal cancer cells. Kumatakenin interacts with ATG5 to reduce its protein level, decrease LC3 level, and reduce the number of autophagosomes in the hippocampus. Kumatakenin binds to Eno3 to upregulate its expression, reduce the stability and expression level of IRP1 mRNA, inhibit ferroptosis, alleviate intestinal inflammation, and restore epithelial barrier function. Kumatakenin enhances the efficacy of antibiotics against pathogenic bacteria, inhibits SARS-CoV-2 replication, and reduces cytokine production. Kumatakenin is applicable to research related to ovarian cancer, esophageal cancer, depression and colitis [5].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0960
CAS No.: 127-71-9
Synonyms: N-Sulfanilylbenzamide
Research Areas:  

Infection Cancer

Sulfabenzamide (N-Sulfanilylbenzamide) is a sulfonamide antibacterial agent. Sulfabenzamide exhibit antibacterial activity against Staphylococcus aureus (ATCC 25923) and Escherichia coli (ATCC 8739). Sulfabenzamide can promote autophagic cell autophagy in breast cancer cells through p53/ DRAM pathway. Sulfabenzamide increases caspase-3 activity, deactivates PARP1 and DNA-PK, downregulates AKT1 and AKT2. Sulfabenzamide can be used for the researches of breast cancer and bacterial infections .
loading...
    loading...
Cat. No.: HY-N0538
CAS No.: 87-99-0
Synonyms: Xylite
Xylitol can be classified as a polyol and sugar alcohol, exhibiting inhibitory activity on cancer cell proliferation. It induces autophagy (Autophagy) and cell death in A549 cells by activating the autophagy signaling pathway, as evidenced by the increased expression of LC3-II and Atg5-Atg12 upon Xylitol treatment. Additionally, Xylitol inhibits acetaldehyde production by Candida species, thereby reducing their carcinogenic potential. In vivo, Xylitol induces alterations in the gut microbiota of mice, which may enhance cholesterol accumulation and upregulate hepatic ChREBP, while also slowing tumor growth in the B16F10 melanoma C57BL/6 mouse model .
loading...
    loading...
Cat. No.: HY-RS01152
Research Areas:  

Others

ATG5 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-167843
CAS No.: 57760-36-8
Alborixin is a polycyclic polyether ionophore Antibiotic. Alborixin is isolated from cultures of Streptomyces albus. Alborixin induces Autophagy via PTEN-mediated inhibition of the AKT pathway, thereby clearing Amyloid-β. Alborixin exhibits activity against Gram-positive bacteria and fungi. Alborixin can be used in the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-RS17532
Research Areas:  

Others

Atg5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Atg5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23989
Research Areas:  

Others

Atg5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Atg5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-183827
CAS No.: 2841473-97-8
Target:  

Autophagy

Research Areas:  

Others

ATG5 PPI-IN-5 is a Autophagy-Related ATG5 protein-protein interaction inhibitor and autophagy inhibitor. The IC50 values of ATG5 PPI-IN-5 for the interactions of ATG5-ATG16L1 and ATG5-TECAIR are >33 μM .
loading...
    loading...
Cat. No.: HY-183731
CAS No.: 2841473-89-8
Target:  

Autophagy

Research Areas:  

Others

ATG5 PPI-IN-1 is a ATG5 protein-protein interaction inhibitor, with an IC50 of 27.43 μM for the ATG5-ATG16L1 interaction and an IC50 of 14.88 μM for the ATG5-TECAIR interaction .
loading...
    loading...
Cat. No.: HY-183826
CAS No.: 2841473-91-2
Target:  

Autophagy

Research Areas:  

Infection Cancer

ATG5 PPI-IN-4 is an autophagy inhibitor targeting ATG5, with an IC50 of 12.78 μM against ATG5-ATG16L1 and an IC50 of 12.00 μM against ATG5-TECAIR. ATG5 PPI-IN-4 blocks the protein interactions between ATG5 and ATG16L1, as well as between ATG5 and TECAIR, disrupts the assembly of the ATG12-ATG5-ATG16L1 ternary complex, inhibits the lipidation modification of LC3/ATG8, and ultimately downregulates cellular autophagy levels. ATG5 PPI-IN-4 can be used in autophagy-related research, such as studies on infection and cancer .
loading...
    loading...
Cat. No.: HY-183732
CAS No.: 2841473-85-4
Target:  

Autophagy

Research Areas:  

Others

ATG5 PPI-IN-2 is a selective inhibitor of ATG5-TECAIR protein-protein interaction, with a IC50 of 19.16 μM. ATG5 PPI-IN-2 also acts as an Autophagy inhibitor .
loading...
    loading...
Cat. No.: HY-183867
CAS No.: 2841473-87-6
Target:  

Autophagy

Research Areas:  

Others

ATG5 PPI-IN-6 is an inhibitor of ATG5 interactions with other proteins, with an IC50 value of 26.92 μM against ATG5-ATG16L1 and 16.34 μM against ATG5-TECAIR. ATG5 PPI-IN-6 inhibits Autophagy in cells .
loading...
    loading...
Cat. No.: HY-W018791R
CAS No.: 73536-69-3
Synonyms: DDB (Standard)
Bifendate (DDB), extracted from Schisandrae chinensis, is an orally active anti-HBV agent against chronic hepatitis B. Bifendate inhibits ATG5-dependent autophagy and attenuates oleic acid-induced lipid accumulation with anti-oxidant properties in vitro. Bifendate can decrease alanine transaminase (ALT) level in mice. Bifendate attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice. Bifendate potently increases the activity of cytochrome proteins (CYPs) and reverse P-gp-mediated multi-drug resistance (MDR) [5] .
loading...
    loading...
Cat. No.: HY-183828
CAS No.: 2841473-95-6
Target:  

Autophagy

Research Areas:  

Cancer

ATG5/TECAIR-IN-2 is an ATG5 inhibitor with target IC50 values >33 μM.ATG5/TECAIR-IN-2 disrupts protein-protein interactions between ATG5 and ATG16L1, and between ATG5 and TECAIR.ATG5/TECAIR-IN-2 inhibits autophagy in mammalian cells .
loading...
    loading...
Cat. No.: HY-183829
CAS No.: 2841473-79-6
Target:  

Autophagy

Research Areas:  

Others

ATG5/TECAIR-IN-3 is a ATG5 inhibitor with autophagy inhibitory activity. ATG5/TECAIR-IN-3 selectively inhibits the ATG5-TECAIR interaction (IC50=31.24 μM) and shows no activity against the ATG5-ATG16L1 interaction .
loading...
    loading...
Cat. No.: HY-183848
CAS No.: 2841473-98-9
Target:  

Autophagy

Research Areas:  

Cancer

ATG5/TECAIR-IN-4 is an ATG5-targeting autophagy inhibitor. ATG5/TECAIR-IN-4 exhibits weak autophagy inhibitory activity. ATG5/TECAIR-IN-4 could be used in cancer-related research .
loading...
    loading...
Cat. No.: HY-183737
CAS No.: 2841473-83-2
Target:  

Autophagy

Research Areas:  

Infection Cancer

ATG5/TECAIR-IN-1 is a ATG5-TECAIR interaction inhibitor with an IC50 of 20.79 μM. ATG5/TECAIR-IN-1 inhibits autophagy. TG5/TECAIR-IN-1 is applicable to research on modulating protein-protein interactions to intervene in autophagy-related diseases, such as infectious diseases and cancers .
loading...
    loading...
Cat. No.: HY-151914
CAS No.: 3037605-45-8
Target:  

Atg7 Autophagy

Research Areas:  

Cancer

Antitumor agent-82 (compound 6g) is a potent anti-tumor agent. Antitumor agent-82 shows anti-proliferative activity. Antitumor agent-82 induces cell Autophagy by the ATG5/ATG7 signaling pathway .
loading...
    loading...
Cat. No.: HY-173133
CAS No.: 3063469-69-9
Target:  

Autophagy Atg7

Research Areas:  

Cancer

Antitumor agent-199 (Compound 4b) is an antitumor agent. Antitumor agent-199 exhibits significant antiproliferative activity against multiple tumor cell lines. Antitumor agent-199 can induce autophagy in cancer cells via the ATG5/ATG7 pathway and can be used in the study of cancer .
loading...
    loading...